CBP-201
CBP-201-CN003
Phase 3 small_molecule active
Quick answer
CBP-201 for Atopic Dermatitis is a Phase 3 program (small_molecule) at Connect Biopharma Holdings Ltd with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Connect Biopharma Holdings Ltd
- Indication
- Atopic Dermatitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active